Works matching AU Mikhael, Joseph


Results: 82
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    P-191: Comparison of efficacy outcomes for Carfilzomib plus Dexamethasone and Daratumumab (KdD) versus Pomalidomide plus Bortezomib and Dexamethasone (PVd) and D-Pd in relapsed or refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S142, doi. 10.1016/S2152-2650(21)02318-1
    By:
    • Chari, Ajai;
    • Dimopoulos, Meletios-Athanasios;
    • Beksac, Meral;
    • Leleu, Xavier;
    • Weisel, Katja;
    • Richter, Joshua;
    • Dirnberger, Franziska;
    • Iskander, Karim;
    • Yusuf, Akeem;
    • Mikhael, Joseph
    Publication type:
    Article
    17
    18
    19
    20
    21

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    22
    23

    Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e27, doi. 10.1016/j.clml.2017.03.046
    By:
    • Kumar, Shaji;
    • Kaufman, Jonathan L.;
    • Mikhael, Joseph;
    • Gasparetto, Cristina;
    • Vij, Ravi;
    • Pegourie, Brigitte;
    • Benboubker, Lofti;
    • Facon, Thierry;
    • Moreau, Philippe;
    • Amiot, Martine;
    • Alzate, Stefanie;
    • Dunbar, Martin;
    • Xu, Tu;
    • Agarwal, Suresh;
    • Leverson, Joel;
    • Ross, Jeremy;
    • Maciag, Paulo;
    • Verdugo, Maria;
    • Touzeau, Cyrille
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 4, p. 549, doi. 10.1111/bjh.15969
    By:
    • Jakubowiak, Andrzej J.;
    • Jasielec, Jagoda K.;
    • Rosenbaum, Cara A.;
    • Cole, Craig E.;
    • Chari, Ajai;
    • Mikhael, Joseph;
    • Nam, Jennifer;
    • McIver, Amanda;
    • Severson, Erica;
    • Stephens, Leonor A.;
    • Tinari, Kathryn;
    • Rosebeck, Shaun;
    • Zimmerman, Todd M.;
    • Hycner, Tyler;
    • Turowski, Agata;
    • Karrison, Theodore;
    • Zonder, Jeffrey A.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 3, p. 352, doi. 10.1111/bjh.12633
    By:
    • Paulus, Aneel;
    • Chitta, Kasyapa;
    • Akhtar, Sharoon;
    • Personett, David;
    • Miller, Kena C.;
    • Thompson, Kevin J.;
    • Carr, Jennifer;
    • Kumar, Shaji;
    • Roy, Vivek;
    • Ansell, Stephen M.;
    • Mikhael, Joseph R.;
    • Dispenzieri, Angela;
    • Reeder, Craig B.;
    • Rivera, Candido E.;
    • Foran, James;
    • Chanan‐Khan, Asher
    Publication type:
    Article
    44
    45

    A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.

    Published in:
    British Journal of Haematology, 2012, v. 156, n. 3, p. 326, doi. 10.1111/j.1365-2141.2011.08949.x
    By:
    • Khan, Meaghan L.;
    • Reeder, Craig B.;
    • Kumar, Shaji K.;
    • Lacy, Marthy Q.;
    • Reece, Donna E.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Greipp, Phillip;
    • Hayman, Suzanne;
    • Zeldenhurst, Steven;
    • Dingli, David;
    • Lust, John;
    • Russell, Stephen;
    • Laumann, Kristina M.;
    • Mikhael, Joseph R.;
    • Leif Bergsagel, P.;
    • Fonseca, Rafael;
    • Vincent Rajkumar, S.;
    • Keith Stewart, A.
    Publication type:
    Article
    46
    47

    Geriatric Assessment in Older Adults with Multiple Myeloma.

    Published in:
    Journal of the American Geriatrics Society, 2019, v. 67, n. 5, p. 987, doi. 10.1111/jgs.15715
    By:
    • Wildes, Tanya M.;
    • Tuchman, Sascha A.;
    • Klepin, Heidi D.;
    • Mikhael, Joseph;
    • Trinkaus, Kathryn;
    • Stockerl‐Goldstein, Keith;
    • Vij, Ravi;
    • Colditz, Graham
    Publication type:
    Article
    48

    Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01149-w
    By:
    • Richardson, Paul G.;
    • Perrot, Aurore;
    • Mikhael, Joseph;
    • Martin, Thomas;
    • Beksac, Meral;
    • Spicka, Ivan;
    • Capra, Marcelo;
    • D'Agostino, Mattia;
    • Sonneveld, Pieter;
    • Bisht, Kamlesh;
    • Fukao, Taro;
    • Zhang, Rick;
    • Tada, Keisuke;
    • Tekle, Christina;
    • Macé, Sandrine;
    • Klippel, Zandra;
    • van de Velde, Helgi;
    • Moreau, Philippe
    Publication type:
    Article
    49
    50

    Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    2023
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Correction Notice